These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 926598)

  • 1. [Use of glucagon in cardiac glycoside poisoning in patients with congestive circulatory insufficiency].
    Sivkov SI
    Kardiologiia; 1977 Sep; 17(9):39-42. PubMed ID: 926598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanisms of development of cardiac glycoside poisoning and its drug prevention in circulatory failure].
    Gendenshteĭn EI; Lemkina SM
    Kardiologiia; 1987 Dec; 27(12):107-11. PubMed ID: 3327992
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of cardiac glycosides on whole body potassium concentration in circulatory insufficiency].
    Lyskova MN; Kruglova ZG
    Kardiologiia; 1985 Dec; 25(12):70-4. PubMed ID: 3937933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Glycoside poisoning in experimental heart failure and its drug correction].
    Gendenshteĭn EI; Lemkina SM; Sernov LN
    Farmakol Toksikol; 1985; 48(6):83-6. PubMed ID: 4085636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nonglycoside drugs in the treatment of congestive circulatory insufficiency].
    Sivkov II
    Ter Arkh; 1982; 54(3):15-20. PubMed ID: 7089881
    [No Abstract]   [Full Text] [Related]  

  • 6. [The cardiac glycoside treatment of circulatory insufficiency in the bradysystolic form of cardiac fibrillation].
    Dolgoplosk NA; Bazilevich MS
    Ter Arkh; 1967 Sep; 39(9):57-60. PubMed ID: 5611705
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of cardiac glycosides in chronic circulatory insufficiency].
    Sivkov II; Kukes VG
    Kardiologiia; 1975 Oct; 15(10):52-8. PubMed ID: 1234914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemodynamic effects of glucagon, isoprenaline and dopamine in patients with congestive circulatory insufficiency].
    Kukes VG; Tsoĭ AN; Iatsenko IV; Sivkov SI; Burian EF
    Kardiologiia; 1982 Sep; 22(9):62-6. PubMed ID: 7143898
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of glucagon in cardiac insufficiency].
    Golikov AP; Berestov AA
    Kardiologiia; 1975 Oct; 15(10):62-5. PubMed ID: 1234916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of chronic heart failure].
    Kaindl F; Kohn P
    Wien Z Inn Med; 1972; 53(12):603-15. PubMed ID: 4603929
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combined use of glucagon and strophanthin in myocardial infarct complicated by severe cardiac insufficiency].
    Riabinin VA; Golikov AP
    Kardiologiia; 1978 Jan; 18(1):62-8. PubMed ID: 342797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current data on the role of cardiac glycosides in the treatment of circulatory insufficiency].
    Valenkevich LN; Lemkina SM
    Klin Med (Mosk); 1989 Jan; 67(1):18-23. PubMed ID: 2654460
    [No Abstract]   [Full Text] [Related]  

  • 13. Glucagon in resistant heart-failure and cardiogenic shock.
    Wilcken DE; Lvoff R
    Lancet; 1970 Jun; 760(1):1315-8. PubMed ID: 4193948
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the problem of the method of prolonged use of cardiac glycosides in patients with mitral defects and chronic circulatory insufficiency].
    Kats GL
    Sov Med; 1967 Apr; 30(4):79-83. PubMed ID: 5608582
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in central hemodynamics and microcirculation during laser therapy in patients with coronary insufficiency].
    Gel'fgat EB; Samedov RI; Kurbanova ZN; Gadzhiev GG
    Kardiologiia; 1993; 33(2):22-3. PubMed ID: 8084121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Positive inotropic therapy of cardiac failure: old and new drugs, controversies and tests].
    Sfrisi C; Cocco G
    Clin Ter; 1984 Oct; 111(2):159-67. PubMed ID: 6239739
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of latent cardiac insufficiency with a new cardiac glycoside].
    Stummer E
    Ther Ggw; 1969 Aug; 108(8):1154-6 passim. PubMed ID: 5379563
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of cardiac insufficiency with a new cardiac glycoside].
    Becker D
    Landarzt; 1965 Jul; 41(19):831-3. PubMed ID: 5320409
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of cardiac glycosides and risk of glioma.
    Seliger C; Meier CR; Jick SS; Uhl M; Bogdahn U; Hau P; Leitzmann MF
    J Neurooncol; 2016 Apr; 127(2):321-8. PubMed ID: 26721242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The treatment of cardiac insufficiency of varying genesis with a new cardiac glycoside].
    Gill E
    Med Welt; 1970 Aug; 34():1472-6. PubMed ID: 5510409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.